Harvard Apparatus Regenerative Technology Inc.
HRGN
$2.18
-$0.17-7.40%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 44.62% | 111.72% | 63.72% | 216.17% | 214.35% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 44.62% | 111.72% | 63.72% | 216.17% | 214.35% |
| Cost of Revenue | 56.55% | 181.44% | 139.26% | 486.79% | 1,083.67% |
| Gross Profit | -25.25% | -48.03% | -63.75% | -6.20% | -40.72% |
| SG&A Expenses | -16.67% | -12.86% | -14.94% | -12.56% | -8.55% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.86% | 6.07% | -0.48% | -7.56% | -3.44% |
| Operating Income | 0.25% | 0.35% | 4.30% | 14.40% | 9.75% |
| Income Before Tax | 0.04% | 7.47% | 11.16% | 20.55% | 16.10% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 0.04% | 7.47% | 11.16% | 20.55% | 16.10% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 0.04% | 7.47% | 11.16% | 20.55% | 16.10% |
| EBIT | 0.25% | 0.35% | 4.30% | 14.40% | 9.75% |
| EBITDA | 0.22% | 0.26% | 4.19% | 14.27% | 9.55% |
| EPS Basic | 9.72% | 17.24% | 21.23% | 30.02% | 24.84% |
| Normalized Basic EPS | 9.67% | 10.79% | 15.61% | 25.48% | 19.93% |
| EPS Diluted | 9.72% | 17.24% | 21.23% | 30.02% | 24.84% |
| Normalized Diluted EPS | 9.67% | 10.79% | 15.61% | 25.48% | 19.93% |
| Average Basic Shares Outstanding | 10.51% | 10.79% | 11.67% | 13.38% | 12.08% |
| Average Diluted Shares Outstanding | 10.51% | 10.79% | 11.67% | 13.38% | 12.08% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |